Search clinical trials for: Fludeoxyglucose PET MRI

Total 10944 results

Michael C Roarke, MD

Completed

Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma

Multiple Myeloma

United States
Weinberg Medical Physics LLC
University of California, Irvine

Terminated

Improving Diagnosis of Breast Cancer by Using a Combined MRI and Positron Emission Mammography (MRI-PEM) System (MRI-PEM)

Breast Cancer
Robert Flavell, MD, PhD
National Cancer Institute (NCI)

Recruiting

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

Multiple Myeloma | Plasma Cell Myeloma

United States
Washington University School of Medicine

Terminated

18F-FLT PET Imaging in Patients With Advanced Melanoma

Melanoma

United States
Tao Xin

Not yet recruiting

Establishment and Evaluation of Multimodal Image Recognition System of Glioma Based on Deep Learning

Glioma
Assistance Publique Hopitaux De Marseille

Terminated

Diagosis of Breast Carcinoma: Characterization of Breast Lesions With CLEARPEMSONIC : Feasibility Study

Breast Carcinoma

France
Cambridge University Hospitals NHS Foundation Trust

Recruiting

Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer (NaRNIA)

Breast Cancer

United Kingdom
University of Alabama at Birmingham

Terminated

FET-PET/MRI for Surgical Assessment of Pediatric Brain Tumors

Pediatric Brain Tumors

United States
University of Oxford

Completed

RHYTHM-I: Investigating Hypoxia in Rectal Tumours (RHYTHM-I)

Hypoxia in Rectal Cancer

United Kingdom
Jeffrey A. Lieberman, MD

Terminated

PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations

Schizophrenia
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Terminated

PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations

Schizophrenia

United States
Maastricht University Medical Center

Completed

MR-PET for Staging and Assessment of Operability in Ovarian Cancer - a Feasibility Study

Ovarian Neoplasms

Netherlands
Università Vita-Salute San Raffaele
IRCCS San Raffaele; Associazione Italiana per la Ricerca sul Cancro

Not yet recruiting

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer (FESTA)

Breast Cancer Female | Lobular Breast Carcinoma | Luminal A Breast Cancer | PET/MRI | Axillary Lymphadenopathy
University of Edinburgh

Completed

PET MRI in Coronary Artery Disease

Coronary Artery Disease

United Kingdom
NYU Langone Health
Dendreon

Terminated

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

Prostate Cancer

United States
First Affiliated Hospital of Fujian Medical University

Not yet recruiting

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Urinary Bladder Neoplasms
Washington University School of Medicine
National Cancer Institute (NCI)

Terminated

Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)

PET/CT

United States
Massachusetts General Hospital

Recruiting

Evaluation of PET/MRI in Children With Cancer

Hematologic Malignancy

United States
Xuzhou Medical University

Unknown

PET-CT/MRI in the Radiotherapy for Prostate Cancer

Prostate Cancer
University Health Network, Toronto

Completed

FCH PET/MRI Parathyroid Localization

Hyperparathyroidism, Primary | Positron-Emission Tomography | 18F-fluorocholine

Canada
Turku University Hospital
GE Healthcare; Blue Earth Diagnostics

Completed

Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI (Flucipro)

Prostate Carcinoma

Finland
Gert Meijer
M.D. Anderson Cancer Center

Completed

PReoperative Identification Of Response to Neoadjuvant Chemoradiotherapy for Esophageal Cancer (PRIOR)

Esophageal Cancer

United States, Netherlands
University of Washington
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Cervical Undifferentiated Carcinoma | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage... and other conditions

United States, Hong Kong, Canada
University of Washington
National Cancer Institute (NCI)

Terminated

FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer

Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer

United States
Institut de cancérologie Strasbourg Europe

Recruiting

Interest of PET-MRI in the Evaluation of the Response After Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma (TEPIREC)

Rectal Cancer

France
IRCCS San Raffaele
IBFM- Consiglio Nazionale delle Ricerche

Recruiting

Axillary Staging in Early Breast Cancer: SNB vs PET/MRI

Breast Cancer | Sentinel Lymph Node | Early-stage Breast Cancer

Italy
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study (IMAHTEP)

NSCLC

France
IRCCS San Raffaele

Recruiting

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer. (RF2021-1237227)

Clinical Suspicion of Prostate Cancer

Italy
Sheffield Teaching Hospitals NHS Foundation Trust

Recruiting

Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications

Head and Neck Cancer

United Kingdom
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Evaluation of the Prognostic Value of PET/MRI in Cardiac Sarcoidosis (SARCASTIM)

Cardiac Sarcoidosis
University Health Network, Toronto

Recruiting

PET-MRI Esophagus Feasibility Study

Esophagogastric Cancer

Canada
Oreste Davide Gentilini
IBFM- Consiglio Nazionale delle Ricerche

Recruiting

Axillary Staging in Node Positive Breast Cancer Patients Receiving PST. SNB vs PET/MRI

Sentinel Lymph Node | Breast Cancer Female | Node-positive Breast Cancer

Italy
Imperial College London

Completed

Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI

Glioma

United Kingdom
Rigshospitalet, Denmark

Terminated

Non-invasive Detection of Male Infertility With FDG-PET/MRI (Spectroscopy and DWI)

Fertility Disorders

Denmark
University Hospitals Cleveland Medical Center

Terminated

Alzheimer's Disease Imaging With PET/MRI - Beta-amyloid

Dementia | Alzheimer Disease

United States
National Institute of Mental Health (NIMH)

Terminated

Novel Positron Emission Tomography (PET) Radiotracer to Image Phosphodiesterase-4B (PDE4B)

Healthy

United States
University Hospital, Limoges

Completed

Wholebody MRI In Lung Cancer StagiNg (WISLON)

Lung Cancer

France
London Health Sciences Centre

Completed

Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI

Rectal Cancer

Canada
University of Cambridge
Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Wellcome Trust and other collaborators

Active, not recruiting

PET Imaging of Giant Cell and Takayasu Arteritis (PITA)

Giant Cell Arteritis | Takayasu Arteritis

United Kingdom
University of California, San Francisco

Terminated

Validation of Combined PET-MR Quantitative Parameters for Cardiac Applications

Cardiac Disease

United States
Turku University Hospital

Completed

Combined PET-MRI in the Diagnostics of Chronic Inflammatory Bowel Diseases (IBD)- a Feasibility Study

IBD

Finland
Assistance Publique - Hôpitaux de Paris

Unknown

Rectal Cancer Response Hybrid Imaging Assessement (RECARHIA)

Rectal Cancer

France
University of Wisconsin, Madison

Terminated

PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning

Head and Neck Neoplasms

United States
Washington University School of Medicine

Completed

Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma

Adenocarcinoma Pancreas

United States
Queen Mary University of London

Unknown

Characterising Metastatic Penile Cancer Using Molecular Imaging - Hybrid MRI-PET [MRI-PET] (MRI-PET)

Squamous Cell Carcinoma of the Penis

United Kingdom
UNC Lineberger Comprehensive Cancer Center

Withdrawn

FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions

Brain Metastasis | Brain Metastases | Brain Lesions

United States
Norwegian University of Science and Technology
University Hospital of North Norway; Haukeland University Hospital; St. Olavs...

Recruiting

Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients

Prostatic Neoplasms | Neoplasm Metastasis

Norway
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

FDG PET-MRI for the Diagnosis of Spinal Cord Lesions

Spinal Cord Neoplasm

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases

Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Brain

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery

Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm

United States

Search clinical trials for: Fludeoxyglucose PET MRI

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations